Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mariko, Maekawa"'
Autor:
Kazuki Otake, Minoru Ubukata, Noboru Nagahashi, Naoki Ogawa, Yoshiji Hantani, Rie Hantani, Tsuyoshi Adachi, Akihiro Nomura, Keishi Yamaguchi, Mariko Maekawa, Hideaki Mamada, Takahisa Motomura, Motohide Sato, Kazuhito Harada
Publikováno v:
ACS Medicinal Chemistry Letters. 14:658-665
Autor:
Mariko MAEKAWA, Tatsuya MAEKAWA, Tomohiko SASASE, Takeshi WAKASHIMA, Atsuhiro UEMURA, Kinuko UNO, Takeshi OHTA, Takahisa YAMADA
Publikováno v:
Experimental Animals; 2024, Vol. 73 Issue 1, p29-40, 12p
Autor:
Yuichi SHINOZAKI, Kenji FUKUI, Mariko MAEKAWA, Kaoru TOYODA, Hiromi YOSHIUCHI, Koji INAGAKI, Kinuko UNO, Katsuhiro MIYAJIMA, Takeshi OHTA
Publikováno v:
Physiological Research; Apr2023, Vol. 72 Issue 2, p209-220, 12p
Autor:
Mariko, Maekawa, Nobuyoshi, Kittaka, Takaaki, Hatano, Ryu, Tokui, Hiroki, Kusama, Saki, Matsui, Minako, Nishio, Fumie, Fujisawa, Keiichiro, Honma, Takahiro, Nakayama, Yasuhiro, Tamaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
We report a case of primary breast rhabdomyosarcoma. A 16-year-old girl noticed tumor of her right breast and consulted a local clinic. From the result of core needle biopsy, breast sarcoma was suspected, so she attended our hospital. Breast ultrason
Autor:
Hiromi Yoshiuchi, Hironobu Tadaki, Chihiro Okuma, Reina Kakefuda, Takeshi Ohta, Yukihito Ishii, Daisuke Tomimoto, Mariko Maekawa, Ryuhei Sano, Yoshiaki Katsuda, Tomohiko Sasase
Publikováno v:
Biological and Pharmaceutical Bulletin. 42:1906-1912
Tumor necrosis factor-α (TNF-α) converting enzyme/a disintegrin and metalloproteinase domain-containing protein 17 (TACE/ADAM17) is a key sheddase that releases TNF-α from its inactive precursor and is thought as a new drug target to inhibit TNF-
Autor:
Nobuyoshi Kittaka, Makoto Ishitobi, Mariko Maekawa, Saki Matsui, Tomoyuki Kurita, Takahiro Nakayama, Ryu Tokui, Hiroki Kusama, Takaaki Hatano, Yasuhiro Tamaki
Publikováno v:
Clinical breast cancer. 22(2)
Background There is little information on the oncological outcomes of breast-conserving surgery (BCS) with immediate reconstruction using a latissimus dorsi myocutaneous flap (LDMF) for breast cancer compared with BCS alone. Patients and Methods We c
Autor:
Mariko MAEKAWA, Tatsuya MAEKAWA, Tomohiko SASASE, Kayoko TAKAGI, Satomi TAKEUCHI, Mari KITAMOTO, Tatsuro NAKAGAWA, Kaoru TOYODA, Noriko KONISHI, Takeshi OHTA, Takahisa YAMADA
Publikováno v:
Physiological Research; Apr2022, Vol. 71 Issue 2, p209-217, 9p
Autor:
Mariko, Maekawa, Hironobu, Tadaki, Daisuke, Tomimoto, Chihiro, Okuma, Ryuhei, Sano, Yukihito, Ishii, Yoshiaki, Katsuda, Hiromi, Yoshiuchi, Reina, Kakefuda, Takeshi, Ohta, Tomohiko, Sasase
Publikováno v:
Biologicalpharmaceutical bulletin. 42(11)
Tumor necrosis factor-α (TNF-α) converting enzyme/a disintegrin and metalloproteinase domain-containing protein 17 (TACE/ADAM17) is a key sheddase that releases TNF-α from its inactive precursor and is thought as a new drug target to inhibit TNF-
Autor:
Hironobu Tadaki, Chihiro Okuma, Daisuke Tomimoto, Takeshi Ohta, Mariko Maekawa, Tomohiko Sasase, Yoshiaki Katsuda
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:3
Autor:
Fukuda Kenji, Shuichi Kimura, Takashi Nakagawa, Toshihiro Kiguchi, Hiromasa Hashimoto, Yushi Matsuo, Kazuhito Harada, Mariko Maekawa, Soejima Yuki, Masanori Shindo, Masaki Takagi, Mikio Hayashi, Naoki Ogawa, Kazuyuki Hirata, Taku Ikenogami, Yuko Shinagawa, Takeo Katsushima, Mitsuru Takahashi, Teruhiko Inoue
Publikováno v:
ACS Medicinal Chemistry Letters. 2:238-242
Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified aminopro